New Myocarditis Findings from Raigmore Hospital Described (Treating hearts and minds: adverse cardiovascular effects of psychiatric medications).

This article focuses on research from Inverness, United Kingdom, examining the adverse cardiovascular effects of psychiatric medications in patients with severe mental illness (SMI). The study highlights that cardiovascular disease (CVD) mortality is approximately 3.3 times higher in patients with SMI compared to the general population, partly due to short- and long-term cardiac risks associated with psychiatric drugs such as selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), antipsychotics, and others. Specific cardiovascular effects include arrhythmias, myocarditis, cardiomyopathy, hypertension, and tachycardia, with pharmacokinetic interactions via the cytochrome P450 system potentially exacerbating these risks. The research emphasizes that understanding these adverse effects can help clinicians improve cardiovascular health outcomes by tailoring psychiatric medication prescriptions for patients with SMI. [Extracted from the article]